Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Reset all filters
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1Cambrex Profarmaco Milano Srl
03 1Honour Lab Limited
Reset all filters
01 3Clorazepate Dipotassium
Reset all filters
01 2India
02 1U.S.A
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-097
Start Marketing Date : 2023-06-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12828-0019
Start Marketing Date : 1987-03-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69037-0067
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Clorazepate Dipotassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clorazepate Dipotassium, including repackagers and relabelers. The FDA regulates Clorazepate Dipotassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clorazepate Dipotassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clorazepate Dipotassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clorazepate Dipotassium supplier is an individual or a company that provides Clorazepate Dipotassium active pharmaceutical ingredient (API) or Clorazepate Dipotassium finished formulations upon request. The Clorazepate Dipotassium suppliers may include Clorazepate Dipotassium API manufacturers, exporters, distributors and traders.
click here to find a list of Clorazepate Dipotassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clorazepate Dipotassium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clorazepate Dipotassium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clorazepate Dipotassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clorazepate Dipotassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clorazepate Dipotassium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clorazepate Dipotassium suppliers with NDC on PharmaCompass.
We have 3 companies offering Clorazepate Dipotassium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?